The PABPC1 protein has diverse roles in gene expression control that span functions in mRNA stability, polyA tail length control, and translation regulation. PABPC1 gene amplifications are detected in roughly 4% of cancer samples, but it is unclear how PABPC1 fits into the picture of cancer progression. Dr. Muller [HHMI Fellow] studies the sequence preferences of PABPC1 protein to understand the mechanistic details that determine which transcripts are subject to PABPC1-mediated regulation. Connecting these sequence preferences to the mis-regulation caused by excess PABPC1 may provide a therapeutic handle for cancers that contain PABPC1 gene amplifications. Dr. Muller received his PhD from the University of California, Berkeley and his BS from Arizona State University, Tempe.
Damon Runyon Researchers
Meet Our ScientistsRyan Y. Muller, PhD
      Project title:     “The molecular determinants of PABP-mediated gene regulation”  
  
      Institution:     Whitehead Institute for Biomedical Research  
  
      Named Award:     HHMI Fellow  
  
      Award Program:     Fellow  
  
      Sponsor(s) / Mentor(s):     David P. Bartel, PhD  
  
      Cancer Type:     All Cancers  
  
      Research Area:     Biochemistry  
   
  





